Hims & Hers Health Raises Full Year 2023 Revenue Guidance From $810M-$830M To $830M-$850M; Consensus $830.75M
Portfolio Pulse from Benzinga Newsdesk
Hims & Hers Health has increased its full year 2023 revenue guidance from $810M-$830M to $830M-$850M. The consensus was $830.75M.

August 07, 2023 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health has raised its 2023 revenue guidance, which could positively impact investor sentiment.
Hims & Hers Health's raised revenue guidance for 2023 indicates a positive outlook for the company's future performance. This could lead to increased investor confidence and potentially a rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100